Plant Health Care PLC
LSE:PHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its Industry Average (31.4), the stock would be worth GBX-47.46 (632% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -5.9 | GBX8.93 |
0%
|
| Industry Average | 31.4 | GBX-47.46 |
-632%
|
| Country Average | 23.2 | GBX-35.06 |
-493%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Plant Health Care PLC
LSE:PHC
|
30.5m GBP | -5.9 | -10.3 | |
| US |
|
Corteva Inc
NYSE:CTVA
|
53.1B USD | 17.8 | 48.7 | |
| CA |
|
Nutrien Ltd
TSX:NTR
|
48.1B CAD | 22.7 | 15.5 | |
| CN |
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
195.9B CNY | 20.1 | 23.1 | |
| CL |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
25.6B USD | 69.3 | 44.2 | |
| CN |
|
Zangge Mining Co Ltd
SZSE:000408
|
139.3B CNY | 76.5 | 29.8 | |
| US |
|
CF Industries Holdings Inc
NYSE:CF
|
18.8B USD | 11.5 | 13.4 | |
| NO |
|
Yara International ASA
OSE:YAR
|
136.5B NOK | 14.4 | 10.4 | |
| SA |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
53.8B SAR | 9.1 | 12.4 | |
| CN |
|
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
|
82.8B CNY | 163.8 | 25 | |
| RU |
|
PhosAgro PAO
MOEX:PHOR
|
882.2B RUB | 21.9 | 7.7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.4 |
| Median | 23.2 |
| 70th Percentile | 35.1 |
| Max | 3 178 983.5 |
Other Multiples
Plant Health Care PLC
Glance View
Plant Health Care Plc engages in the provision biological products. The company is headquartered in Raleigh, North Carolina and currently employs 45 full-time employees. The company went IPO on 2004-07-06. The firm's segments include Americas, Mexico, and Rest of World. The company offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. Its biological products help growers to protect their crops from stress and diseases. Its lead product, Harpin ab, is a recombinant protein developed from the naturally occurring Harpin proteins, which act as a biostimulant, promoting the yield and quality of crops. The company is also focused on the research and development of its Plant Response Elicitor technology (PREtec) platform. The company is developing six lead products from three platforms, including Innatus 3G platform, which targets growth and disease resistance; T-Rex 3G platform, which targets nematode defense, while the Y-Max 3G platform delivers increased yield and growth.
